CAR-T cell therapy is one of the newest and most promising treatments available for blood cancer. These treatments aid in the battle against cancer by utilizing your body's immune system.
Factors affecting the cost of CAR-T:
- Development and Manufacturing Costs: The scientific manipulation of a patient's T-cells to generate chimeric antigen receptors that specifically target cancer cells is the basis for CAR-T treatment. CAR-T cell development and production are intricate and costly processes requiring specialized laboratory equipment and methods. The total cost of CAR-T therapy is greatly increased by these up-front expenses.
- Type of Cancer: Certain cancers, including some forms of leukemia and lymphoma, have been approved for treatment with CAR-T therapy. The cost of CAR-T therapy and the intricacy of the treatment regimen may vary depending on the particular form of cancer being treated.
- Development and Manufacturing Costs: The scientific manipulation of a patient's T-cells to generate chimeric antigen receptors that specifically target cancer cells is the basis for CAR-T treatment. CAR-T cell development and production are intricate and costly processes requiring specialized laboratory equipment and methods. The total cost of CAR-T therapy is greatly increased by these up-front expenses.
- Type of Cancer: Certain cancers, including some forms of leukemia and lymphoma, have been approved for treatment with CAR-T therapy. The cost of CAR-T therapy and the intricacy of the treatment regimen may vary depending on the particular form of cancer being treated.
- Post-treatment Monitoring and Support: After receiving CAR-T therapy, patients need to be closely watched for any adverse effects, such as neurotoxicity and cytokine release syndrome (CRS), and their response to treatment needs to be continuously assessed. The total cost of treatment should account for the expenses of supportive care, side effect control, and monitoring following treatment.
- Geographic Location: The cost of healthcare varies by nation and location. Healthcare expenditures, even those for cutting-edge treatments like CAR-T therapy, are typically higher in urban areas or in locations with higher cost of living.
- Supply and Demand Dynamics: CAR-T therapy availability may be restricted in some areas, and treatment costs may be impacted by supply and demand dynamics. The possibility exists that treatment prices could go down over time as more facilities start to provide CAR-T therapy and as manufacturing procedures become more efficient.
| Country | Cost | Local_currency |
|---|---|---|
| United Kingdom | USD 373000 | 294670 |
| Turkey | USD 443200 | 13358048 |
| Spain | USD 375000 | 345000 |
| United States | USD 289550 | 289550 |
| Singapore | USD 251388 | 336860 |
CAR T-cell therapy represents a groundbreaking approach to harnessing the power of the body's immune system to combat cancer. By modifying T cells, a subset of white blood cells, in a laboratory setting, these cells are empowered to recognize and eliminate cancer cells with precision. Often categorized as a form of cell-based gene therapy, CAR T-cell therapy involves altering the genetic makeup of T cells, equipping them with the ability to target specific cancer antigens.
This innovative treatment has demonstrated remarkable efficacy, particularly in cases where conventional therapies have proven ineffective. Its ability to reprogram the immune system to target and destroy cancer cells marks a significant advancement in cancer treatment strategies.
Classification:
CAR T cell therapy is classified as follows:
- Structure-based classification:
- First-generation CAR T-cells: These CAR T-cells typically consist of an antigen-binding domain (single-chain variable fragment, scFv) linked to a T-cell activation domain, such as the CD3ζ chain. They lack additional co-stimulatory domains.
- Second-generation CAR T-cells: These CAR T-cells include an additional co-stimulatory domain, such as CD28 or 4-1BB (CD137), along with the CD3ζ chain. The presence of co-stimulatory domains enhances T-cell activation and persistence.
- Third-generation CAR T-cells: These CAR T-cells incorporate two co-stimulatory domains along with the CD3ζ chain, aiming to further enhance T-cell function and anti-tumor activity.
Antigen-based classification: It includes
- CD19-targeted CAR T-cells: CD19 is a common target for CAR T-cell therapy and is used in the treatment of B-cell malignancies such as acute lymphoblastic leukemia (ALL) and certain types of lymphoma.
- Other antigen-targeted CAR T-cells: CAR T-cells can be engineered to target a variety of antigens expressed on cancer cells, including but not limited to BCMA (B-cell maturation antigen), CD22, CD30, and EGFRvIII.
- T-cell harvesting: T cells are removed from the patient's blood by processing.
- Genetic alteration: T cells are designed in the laboratory to express CAR proteins targeting cancer cells.
- Expansion: Modified T cells are expanded to therapeutic levels.
- Infusion: Patient receives an intravenous infusion of CAR T cells.
- Monitoring: Intensive monitoring, often in the hospital, for side effects and reactions.
- Cytokine Release Syndrome (CRS)
- Neurotoxicity
- Infections
- Low blood counts
- Relapse or non-response
Would you like some help? We are available.
Get Help
Gleneagles Hospital Mumbai
Mumbai, India
- Gleneagles Hospital, Parel, Mumbai, is a premier quaternary-care multispeciality hospital and a top destination for complex medical care in Western India.
- Renowned for multi-organ transplants and advanced surgeries, the hospital offers specialised treatment across Cardiology, Neurology, Gastroenterology, Hepatology, Nephrology, Urology, Orthopaedics, Critical Care, Interventional Radiology, Gynaecology, and General Medicine.
- Equipped with state-of-the-art diagnostic and surgical technology, including 3-Tesla MRI, 128-slice CT Scan, Bi-plane Cath Lab, and robotic surgery systems, Gleneagles provides integrated, patient-focused care.
- Its expert team of doctors, nurses, and support staff ensures high standards of safety, efficiency, and compassionate care, making it a trusted healthcare destination for patients in Mumbai and beyond.
Max Super Specialty Hospital, Vaishali
Ghaziabad, India
- Max Super Speciality Hospital, Vaishali, Ghaziabad, is a leading multi-speciality hospital with 387+ beds and 37+ clinical specialities, offering advanced care in Cardiology, Neuro Sciences, Oncology, Orthopaedics, Transplants, Gastroenterology, and Reconstructive Surgery.
- Supported by 389+ doctors and 1038+ trained staff, the hospital combines state-of-the-art technology, including robotic surgery and advanced imaging systems, with compassionate, patient-centred care.
- Accredited by NABH and NABL, Max Vaishali is a trusted destination for both domestic and international patients seeking high-quality, integrated medical services.
Max Hospital, Gurgaon
Gurgaon, India
- Max Hospital Gurugram is a leading multi-speciality healthcare centre in Haryana, renowned for its advanced clinical expertise and patient-focused care.
- Established in 2007, it is part of the trusted Max Healthcare network and has treated over 500,000 patients across 35+ specialities.
- The hospital is equipped with modern medical technology, internationally trained doctors, and superior clinical infrastructure.
- Known for its excellence in Cardiology, Oncology, Neurosciences, Orthopaedics, Gastroenterology, and Women & Child Care, Max Hospital is a preferred choice for both domestic and international patients seeking high-quality treatment with compassionate care.
Fortis Escorts Heart Institute, Okhla
Delhi, India
Fortis Escorts Heart Institute, located in New Delhi, was founded in 1988 and is a JCI-accredited cardiac care centre, as well as the largest private heart hospital in the Asia-Pacific region. The hospital has 285 beds, five cath labs, state-of-the-art ICUs, and NABL-accredited labs and offers advanced cardiac care surgery 24?7. The hospital also provides advanced cardiac treatment, but is particularly well-known for heart transplants as well as minimally invasive cardiac surgery and paediatric cardiology. The hospital offers world-class facilities and patient-centric services, providing comprehensive support to all international patients.
Fortis Malar Hospital
Chennai, India
Fortis Healthcare Chennai, part of India’s leading Fortis network with 33 hospitals and 5,700+ beds, is a 180-bed multispecialty facility featuring 60 ICU beds, 4 advanced OTs, and a digital cath lab. Staffed by 160 consultants, it delivers world-class, patient-centric care across cardiology, neurology, orthopaedics, and critical care. It has 4 JCI & 26 NABH accredited Hospitals.
VM Medical Park Ankara
Ankara, Turkey
Types of CAR-T in VM Medical Park Ankara and its associated cost
| Treatment Option | Approximate Cost Range (USD) | Approximate Cost Range (TRY) |
|---|---|---|
| CAR-T | 73817 - 103264 | 2238558 - 3003734 |
- Address: Kent Koop Mah., Medical Park Ankara Hastanesi, 1868. Sok., Batkent/Yenimahalle/Yenimahalle/Ankara, Turkey
- Facilities related to VM Medical Park Ankara: Online Doctor Consultation, Post operative followup, Mobility Accessible Rooms, Rehabilitation, Air Ambulance
Medical Park Tokat Hospital
Tokat, Turkey
Types of CAR-T in Medical Park Tokat Hospital and its associated cost
| Treatment Option | Approximate Cost Range (USD) | Approximate Cost Range (TRY) |
|---|---|---|
| CAR-T | 74303 - 101507 | 2162322 - 3029444 |
- Address: Yeilrmak, Medical Park Tokat Hastanesi, Vali Zekai G
- Facilities related to Medical Park Tokat Hospital: Health Insurance Coordination, Mobility Accessible Rooms, Private Rooms, Religious Facilities, Nursery / Nanny Services
VM Medical Park Samsun Hospital
Samsun, Turkey
Types of CAR-T in VM Medical Park Samsun Hospital and its associated cost
| Treatment Option | Approximate Cost Range (USD) | Approximate Cost Range (TRY) |
|---|---|---|
| CAR-T | 73812 - 103354 | 2161333 - 3076349 |
- Address: Cumhuriyet, Medical Park, 39. Sokak, Atakum/Samsun, Turkey
- Facilities related to VM Medical Park Samsun Hospital: Online Doctor Consultation, Post operative followup, Mobility Accessible Rooms, Rehabilitation, Air Ambulance
Centro Medico Teknon
Barcelona, Spain
Apart from in-detail treatment procedures available, Centro Medico Teknon located in Barcelona, Spain has a wide variety of facilities available for International Patients. Some of the facilities which are provided by them are Accommodation, Airport Transfer, Choice of Meals, Interpreter, SIM, TV inside room. Also listed below are some of the most prominent infrastructural details:
- 60,000 square meters of area
- 211 wards
- International visitors program to manage the patient base
- Cardiovascular Institute and Oncology Institute as specialised centres
- Assisted Reproduction availaibility
- Checkup program
- Plastic & Reparative surgery capacities
Hospital Quironsalud Barcelona
Barcelona, Spain
Apart from in-detail treatment procedures available, Hospital Quironsalud Barcelona located in Barcelona, Spain has a wide variety of facilities available for International Patients. Some of the facilities which are provided by them are Accommodation, Airport Transfer, Choice of Meals, Interpreter, SIM, TV inside room. Also listed below are some of the most prominent infrastructural details:
- There are more than 50 healthcare specialties in the hospital.
- It has different kinds of rooms such as over 130 private rooms, 56 suits, and more than 150 consultation rooms.
- There are more than 14 operation theatres and 1 robotic surgery theatre is also present.
- Technologically advanced devices are present in the hospital such as 1 linear accelerator, 2 CAT and 3 MRI scanners.
- Accommodation, flight booking, transfers and interpreters are available.
Need Some Advice From Our Experts?
Request a Call Back Now!
Our team of healthcare experts would be happy to assist you
+99Process Involved for CAR-T
- Preoperative Stage: An assessment of the patient's medical history, including testing to determine eligibility for CAR-T therapy and identify the target antigen on cancer cells.
- Treatment Plan Discussion: An oncologist discusses the procedure of CAR-T therapy, including potential dangers, advantages, and side effects.
- Therapeutic Stage: T-cells are extracted from the patient, modified in the lab to express a chimeric antigen receptor (CAR), and reintroduced into the patient to target and destroy cancer cells.
- Postoperative Phase: Closely monitor for side effects. Follow-ups are scheduled regularly to check the response and treat any complications.
- Cancer patients, especially those suffering from blood cancers like leukemia, lymphoma, and multiple myeloma.
- Patients who have not responded to previous therapies, such as chemotherapy or radiation.
- Patients in good overall health with a functioning immune system.
- Individuals who have specific genetic markers that qualify them for CAR-T treatment.
- Targeted Action: CAR-T treatment specifically targets cancer cells, increasing efficacy while minimising damage to healthy cells.
- Potential for Remission: Can result in long-term remission, even in people with difficult-to-treat cancer.
- Minimally Invasive: The treatment consists mainly of an outpatient procedure for T-cell collection, with the therapy provided via infusion.
- Fill out the inquiry form: Fill out the form to provide us with the relevant information about your condition.
- Consult with Our Healthcare Expert: One of our qualified specialists will contact you for a consultation.
- Receive a Detailed Treatment Plan: After examining your situation, we will provide you with a detailed treatment plan that includes expert views and cost breakdowns for various choices.
- Choose your preferred option: Choose the treatment option that suits you the best.
